Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Hepatitis C

Free Subscription Articles published in J Viral Hepat Retrieve available abstracts of 203 articles: HTML format

Single Articles

June 2008
1. POYNARD T , Munteanu M, Ngo Y, Moussalli J, et al
   FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.
   J Viral Hepat. 2008;15:472-3.
   PubMed     Related articles   
   
   
   May 2008
2. TARANTINO G , Basile V, Conca P, Ariello M, et al
   Could the depression of obese patients suffering from chronic hepatitis C be temporarily improved?
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. TSENG FC , Edlin BR, Zhang M, Kral A, et al
   The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. WEILAND O , Hollander A, Mattsson L, Glaumann H, et al
   Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. CHOU R , Carson S, Chan BK
   Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. DERBALA MF , El Dweik NZ, Al Kaabi SR, Al-Marri AD, et al
   Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. SCHIAVON LL , Narciso-Schiavon JL, Carvalho Filho RJ, Sampaio JP, et al
   Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. ZAMPINO R , Ingrosso D, Durante-Mangoni E, Capasso R, et al
   Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. CUEVAS JM , Torres-Puente M, Jimenez-Hernandez N, Bracho MA, et al
   Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment response.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. SHUDO E , Ribeiro RM, Perelson AS
    Modelling hepatitis C virus kinetics during treatment with pegylated interferon alpha-2b: errors in the estimation of viral kinetic parameters.
    J Viral Hepat. 2008;15:357-62.
    PubMed     Related articles    Abstract available
    
    
    April 2008
11. FABRIZI F , Ganeshan SV, Lunghi G, Messa P, et al
    Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. THOMSON EC , Main J
    Epidemiology of hepatitis C virus infection in HIV-infected individuals.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. NGUYEN TH , Jacobs P, Hanrahan A, Fraser-Lee N, et al
    Health care costs of persons with newly diagnosed hepatitis C virus: a population-based, observational study.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. STRAUSS R , Torner A, Duberg AS, Hultcrantz R, et al
    Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. DUBERG AS , Torner A, Daviethsdottir L, Aleman S, et al
    Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. SEBASTIANI G , Vario A, Guido M, Alberti A, et al
    Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    J Viral Hepat. 2008;.
    PubMed     Related articles   
    
    
    
17. KANG SM , Choi SH, Park CY, Kim MH, et al
    Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication.
    J Viral Hepat. 2008;15:305-13.
    PubMed     Related articles    Abstract available
    
    
    
18. NAPOLI N , Giannelli G, Antonaci A, Antonaci S, et al
    The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response.
    J Viral Hepat. 2008;15:300-4.
    PubMed     Related articles    Abstract available
    
    
    
19. NAKAMURA J , Toyabe SI, Aoyagi Y, Akazawa K, et al
    Economic impact of extended treatment with peginterferon alpha-2a and ribavirin for slow hepatitis C virologic responders.
    J Viral Hepat. 2008;15:293-9.
    PubMed     Related articles    Abstract available
    
    
    
20. YE L , Peng JS, Wang X, Wang YJ, et al
    Methamphetamine enhances Hepatitis C virus replication in human hepatocytes.
    J Viral Hepat. 2008;15:261-70.
    PubMed     Related articles    Abstract available
    
    
    
21. BANI-SADR F , Lapidus N, Melchior JC, Ravaux I, et al
    Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.
    J Viral Hepat. 2008;15:255-60.
    PubMed     Related articles    Abstract available
    
    
    March 2008
22. MCHUTCHISON J , Sulkowski M
    Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. WARD CL , Dev A, Rigby S, Symonds WT, et al
    Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. BORTOLAMI M , Kotsafti A, Cardin R, Farinati F, et al
    Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. AGHEMO A , Rumi MG, Colombo M
    Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?
    J Viral Hepat. 2008;.
    PubMed     Related articles   
    
    
    
26. CIESEK S , Liermann H, Hadem J, Greten T, et al
    Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
    J Viral Hepat. 2008;15:200-11.
    PubMed     Related articles    Abstract available
    
    
    
27. TORRES-PUENTE M , Cuevas JM, Jimenez-Hernandez N, Bracho MA, et al
    Genetic variability in hepatitis C virus and its role in antiviral treatment response.
    J Viral Hepat. 2008;15:188-99.
    PubMed     Related articles    Abstract available
    
    
    
28. BRUCE MG , Bruden D, McMahon BJ, Christensen C, et al
    Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
    J Viral Hepat. 2008;15:179-87.
    PubMed     Related articles    Abstract available
    
    
    February 2008
29. SHUDO E , Ribeiro RM, Perelson AS
    Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon alpha-2b.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. TARANTINO G , Cabibi D, Camma C, Alessi N, et al
    Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. GIGI E , Raptopoulou-Gigi M, Kalogeridis A, Masiou S, et al
    Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    J Viral Hepat. 2008;15:145-54.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
32. VILLACRES MC , Literat O, Degiacomo M, Du W, et al
    Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.
    J Viral Hepat. 2008;15:137-44.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
33. REDDY KR , Govindarajan S, Marcellin P, Bernstein D, et al
    Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.
    J Viral Hepat. 2008;15:129-36.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
34. MOSLEY JW , Operskalski EA, Tobler LH, Buskell ZJ, et al
    The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
    J Viral Hepat. 2008;15:120-8.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
35. FRESHWATER DA , O'Donnell K, Mutimer DJ
    Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy.
    J Viral Hepat. 2008;15:115-9.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
36. FABRIZI F , Dixit V, Messa P, Martin P, et al
    Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
    J Viral Hepat. 2008;15:79-88.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
37. BOUSTIERE CH , Napoleon B, Delasalle P, Coulom P, et al
    Digestive endoscopies are not a risk factor for transmission of virus C.
    J Viral Hepat. 2008;15:155.
    PubMed     Related articles   
    
    
    January 2008
38. MATHEI C , Van Dooren S, Lemey P, Van Damme P, et al
    The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. YU H , Babiuk LA, van Drunen Littel-van den Hurk S
    Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. SHEA DO , Tuite H, Farrell G, Codd M, et al
    Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV / HIV co-infected individuals.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. HAMED MR , Tarr AW, McClure CP, Ball JK, et al
    Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. DE LEDINGHEN V , Barreiro P, Foucher J, Labarga P, et al
    Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. RUYS TA , Nanlohy NM, van den Berg CH, Hassink E, et al
    HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. DE P , Roy E, Boivin JF, Cox J, et al
    Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. BLACKARD JT , Sherman KE
    HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. MANN AG , Trotter CL, Adekoyejo Balogun M, Ramsay ME, et al
    Hepatitis C in ethnic minority populations in England.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. BARNES E , Salio M, Cerundolo V, Francesco L, et al
    Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
48. YOUNOSSI ZM , Nader FH, Bai C, Sjogren R, et al
    A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
49. SCHOTT E , Witt H, Neumann K, Bergk A, et al
    Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy.
    J Viral Hepat. 2008;15:71-8.
    PubMed     Related articles    Abstract available
    
    
    
50. FERRARO D , Giglio M, Bonura C, Di Marco V, et al
    Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay.
    J Viral Hepat. 2008;15:66-70.
    PubMed     Related articles    Abstract available
    
    
    
51. HUNG CH , Chen CH, Lee CM, Wu CM, et al
    Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma.
    J Viral Hepat. 2008;15:58-65.
    PubMed     Related articles    Abstract available
    
    
    
52. POWIS J , Peltekian KM, Lee SS, Sherman M, et al
    Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.
    J Viral Hepat. 2008;15:52-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
53. DEUTSCH M , Hadziyannis SJ
    Old and emerging therapies in chronic hepatitis C: an update.
    J Viral Hepat. 2008;15:2-11.
    PubMed     Related articles    Abstract available
    
    
    December 2007
54. SEBASTIANI G , Vario A, Guido M, Alberti A, et al
    Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. NUNEZ M , Ocampo A, Aguirrebengoa K, Cervantes M, et al
    Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. PEREZ-BERNA AJ , Veiga AS, Castanho MA, Villalain J, et al
    Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. GONZALEZ SA , Zhang C, Fiel MI, Chung S, et al
    Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. ROINGEARD P , Hourioux C
    Hepatitis C virus core protein, lipid droplets and steatosis.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. ANTAKI N , Hermes A, Hadad M, Ftayeh M, et al
    Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. HICKMAN M , McDonald T, Judd A, Nichols T, et al
    Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. THOMSON BJ , Kwong G, Ratib S, Sweeting M, et al
    Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. BUTT AA , Khan UA, McGinnis KA, Skanderson M, et al
    Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans.
    J Viral Hepat. 2007;14:890-6.
    PubMed     Related articles    Abstract available
    
    
    
63. ROWAN PJ , Dunn NJ, El-Serag HB, Kunik ME, et al
    Views of hepatitis C virus patients delayed from treatment for psychiatric reasons.
    J Viral Hepat. 2007;14:883-9.
    PubMed     Related articles    Abstract available
    
    
    
64. TALIANI G , Rucci P, Biliotti E, Cirrincione L, et al
    Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection.
    J Viral Hepat. 2007;14:875-882.
    PubMed     Related articles    Abstract available
    
    
    
65. PALMATEER NE , Hutchinson SJ, McLeod A, Codere G, et al
    Comparison of deaths related to Hepatitis C and AIDS in Scotland.
    J Viral Hepat. 2007;14:870-4.
    PubMed     Related articles    Abstract available
    
    
    
66. BERENGUER J , Bellon JM, Miralles P, Alvarez E, et al
    Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data.
    J Viral Hepat. 2007;14:859-69.
    PubMed     Related articles    Abstract available
    
    
    
67. ZHOU Y , Lukes Y, Anderson J, Fileta B, et al
    Hepatitis C virus E2 envelope protein induces dendritic cell maturation.
    J Viral Hepat. 2007;14:849-58.
    PubMed     Related articles    Abstract available
    
    
    
68. FARINATI F , Cardin R, Bortolami M, Burra P, et al
    Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.
    J Viral Hepat. 2007;14:821-9.
    PubMed     Related articles    Abstract available
    
    
    November 2007
69. EISENBACH C , Neumann-Haefelin C, Freyse A, Korsukewitz T, et al
    Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus.
    J Viral Hepat. 2007;14:817-9.
    PubMed     Related articles   
    
    
    
70. BONNARD P , Lescure FX, Amiel C, Guiard-Schmid JB, et al
    Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    J Viral Hepat. 2007;14:806-11.
    PubMed     Related articles    Abstract available
    
    
    
71. YEUNG LT , To T, King SM, Roberts EA, et al
    Spontaneous clearance of childhood hepatitis C virus infection.
    J Viral Hepat. 2007;14:797-805.
    PubMed     Related articles    Abstract available
    
    
    
72. WITTHOFT T , Moller B, Wiedmann KH, Mauss S, et al
    Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial.
    J Viral Hepat. 2007;14:788-96.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
73. KOIRALA J , Gandotra SD, Rao S, Sangwan G, et al
    Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy.
    J Viral Hepat. 2007;14:782-7.
    PubMed     Related articles    Abstract available
    
    
    
74. JESSNER W , Watkins-Riedel T, Muller C, Formann E, et al
    Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.
    J Viral Hepat. 2007;14:775-81.
    PubMed     Related articles    Abstract available
    
    
    
75. INCHAUSPE G , Michel ML
    Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
    J Viral Hepat. 2007;14 Suppl 1:97-103.
    PubMed     Related articles    Abstract available
    
    
    
76. ROCHE B , Samuel D
    Risk factors for hepatitis C recurrence after liver transplantation.
    J Viral Hepat. 2007;14 Suppl 1:89-96.
    PubMed     Related articles    Abstract available
    
    
    
77. HEATHCOTE EJ
    Antiviral therapy: chronic hepatitis C.
    J Viral Hepat. 2007;14 Suppl 1:82-8.
    PubMed     Related articles    Abstract available
    
    
    
78. CHEVALIEZ S , Pawlotsky JM
    Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C.
    J Viral Hepat. 2007;14 Suppl 1:77-81.
    PubMed     Related articles    Abstract available
    
    
    
79. DREUX M , Cosset FL
    The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies.
    J Viral Hepat. 2007;14 Suppl 1:68-76.
    PubMed     Related articles    Abstract available
    
    
    
80. BRASS V , Moradpour D, Blum HE
    Hepatitis C virus infection: in vivo and in vitro models.
    J Viral Hepat. 2007;14 Suppl 1:64-7.
    PubMed     Related articles    Abstract available
    
    
    October 2007
81. RAMOS-CASALS M , Forns X, Brito-Zeron P, Vargas A, et al
    Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.
    J Viral Hepat. 2007;14:736-42.
    PubMed     Related articles    Abstract available
    
    
    
82. BENET T , D'Oliveira A Jr, Voirin N, Livrozet JM, et al
    Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort.
    J Viral Hepat. 2007;14:730-735.
    PubMed     Related articles    Abstract available
    
    
    
83. DI BISCEGLIE AM , Ghalib RH, Hamzeh FM, Rustgi VK, et al
    Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.
    J Viral Hepat. 2007;14:721-9.
    PubMed     Related articles    Abstract available
    
    
    
84. MASARONE M , La Mura V, Bruno S, Gaeta GB, et al
    Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    J Viral Hepat. 2007;14:714-20.
    PubMed     Related articles    Abstract available
    
    
    
85. TURAL C , Sola R, Rubio R, Santin M, et al
    Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.
    J Viral Hepat. 2007;14:704-13.
    PubMed     Related articles    Abstract available
    
    
    
86. FABRIZI F , Takkouche B, Lunghi G, Dixit V, et al
    The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.
    J Viral Hepat. 2007;14:697-703.
    PubMed     Related articles    Abstract available
    
    
    
87. BUTT AA , Skanderson M, McGinnis KA, Ahuja T, et al
    Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis.
    J Viral Hepat. 2007;14:688-96.
    PubMed     Related articles    Abstract available
    
    
    
88. ZEREMSKI M , Petrovic LM, Talal AH
    The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
    J Viral Hepat. 2007;14:675-87.
    PubMed     Related articles    Abstract available
    
    
    September 2007
89. KURBANOV F , Tanaka Y, Elkady A, Oyunsuren T, et al
    Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia.
    J Viral Hepat. 2007;14:667-74.
    PubMed     Related articles    Abstract available
    
    
    
90. HICKMAN M , Hope V, Brady T, Madden P, et al
    Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.
    J Viral Hepat. 2007;14:645-52.
    PubMed     Related articles    Abstract available
    
    
    
91. SAGIR A , Heintges T, Akyazi Z, Oette M, et al
    Therapy outcome in patients with chronic hepatitis C: role of therapy supervision by expert hepatologists.
    J Viral Hepat. 2007;14:633-8.
    PubMed     Related articles    Abstract available
    
    
    
92. RICHMOND JA , Dunning TL, Desmond PV
    Health professionals' attitudes toward caring for people with hepatitis C.
    J Viral Hepat. 2007;14:624-32.
    PubMed     Related articles    Abstract available
    
    
    
93. STROFFOLINI T , Sagnelli E, Mele A, Cottone C, et al
    HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
    J Viral Hepat. 2007;14:618-623.
    PubMed     Related articles    Abstract available
    
    
    
94. TRUJILLO-MURILLO K , Alvarez-Martinez O, Garza-Rodriguez L, Martinez-Rodriguez H, et al
    Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
    J Viral Hepat. 2007;14:608-17.
    PubMed     Related articles    Abstract available
    
    
    
95. YONEDA M , Saito S, Ikeda T, Fujita K, et al
    Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.
    J Viral Hepat. 2007;14:600-7.
    PubMed     Related articles    Abstract available
    
    
    
96. BANI-SADR F , Goderel I, Penalba C, Billaud E, et al
    Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
    J Viral Hepat. 2007;14:639-644.
    PubMed     Related articles    Abstract available
    
    
    August 2007
97. SIAGRIS D , Vafiadis G, Michalaki M, Lekkou A, et al
    Serum adiponectin in chronic hepatitis C and B.
    J Viral Hepat. 2007;14:577-83.
    PubMed     Related articles    Abstract available
    
    
    
98. SWEETING MJ , De Angelis D, Brant LJ, Harris HE, et al
    The burden of hepatitis C in England.
    J Viral Hepat. 2007;14:570-6.
    PubMed     Related articles    Abstract available
    
    
    
99. WEBSTER D , Ahmed R, Tandon P, Chui L, et al
    Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection.
    J Viral Hepat. 2007;14:564-9.
    PubMed     Related articles    Abstract available
    
    
    
100. PRADAT P , Tillmann HL, Sauleda S, Braconier JH, et al
     Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
     J Viral Hepat. 2007;14:556-63.
     PubMed     Related articles    Abstract available
     
     
     
101. PHAM TN , Mulrooney-Cousins PM, Mercer SE, Macparland SA, et al
     Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.
     J Viral Hepat. 2007;14:537-48.
     PubMed     Related articles    Abstract available
     
     
     
102. GERKENS S , Nechelput M, Annemans L, Peraux B, et al
     A health economic model to assess the cost-effectiveness of PEG IFN alpha-2a and ribavirin in patients with mild chronic hepatitis C.
     J Viral Hepat. 2007;14:523-36.
     PubMed     Related articles    Abstract available
     
     
     
103. FRANCESCHINI B , Russo C, Dioguardi N, Grizzi F, et al
     Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis.
     J Viral Hepat. 2007;14:549-55.
     PubMed     Related articles    Abstract available
     
     
     July 2007
104. SEMMO N , Krashias G, Willberg C, Klenerman P, et al
     Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
     J Viral Hepat. 2007;14:492-502.
     PubMed     Related articles    Abstract available
     
     
     
105. HOFMANN WP , Fernandez B, Herrmann E, Welsch C, et al
     Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.
     J Viral Hepat. 2007;14:484-91.
     PubMed     Related articles    Abstract available
     
     
     
106. ZEKRI AR , Haleem HA, Esmat GE, Bahnassy AA, et al
     Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.
     J Viral Hepat. 2007;14:468-77.
     PubMed     Related articles    Abstract available
     
     
     
107. ROULOT D , Bourcier V, Grando V, Deny P, et al
     Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.
     J Viral Hepat. 2007;14:460-7.
     PubMed     Related articles    Abstract available
     
     
     
108. ARBUTHNOT P , Longshaw V, Naidoo T, Weinberg MS, et al
     Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.
     J Viral Hepat. 2007;14:447-59.
     PubMed     Related articles    Abstract available
     
     
     June 2007
109. MICALLEF JM , Macdonald V, Jauncey M, Amin J, et al
     High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
     J Viral Hepat. 2007;14:413-8.
     PubMed     Related articles    Abstract available
     
     
     
110. MIYATAKE H , Kanto T, Inoue M, Sakakibara M, et al
     Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
     J Viral Hepat. 2007;14:404-12.
     PubMed     Related articles    Abstract available
     
     
     
111. ASAHINA Y , Izumi N, Umeda N, Hosokawa T, et al
     Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
     J Viral Hepat. 2007;14:396-403.
     PubMed     Related articles    Abstract available
     
     
     
112. MARTIN-CARBONERO L , Barreiro P, Jimenez-Galan G, Garcia-Berriguete R, et al
     Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
     J Viral Hepat. 2007;14:392-5.
     PubMed     Related articles    Abstract available
     
     
     
113. RAMOS B , Nunez M, Rendon A, Berdun MA, et al
     Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
     J Viral Hepat. 2007;14:387-91.
     PubMed     Related articles    Abstract available
     
     
     
114. SULKOWSKI MS , Benhamou Y
     Therapeutic issues in HIV/HCV-coinfected patients.
     J Viral Hepat. 2007;14:371-86.
     PubMed     Related articles    Abstract available
     
     
     May 2007
115. MORIONDO M , Resti M, Betti L, Indolfi G, et al
     SEN virus co-infection among HCV-RNA-positive mothers, risk of transmission to the offspring and outcome of child infection during a 1-year follow-up.
     J Viral Hepat. 2007;14:355-9.
     PubMed     Related articles    Abstract available
     
     
     
116. WELKER MW , Hofmann WP, Welsch C, von Wagner M, et al
     Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients.
     J Viral Hepat. 2007;14:338-49.
     PubMed     Related articles    Abstract available
     
     
     
117. TIMM J , Neukamm M, Kuntzen T, Kim AY, et al
     Characterization of full-length hepatitis C virus genotype 4 sequences.
     J Viral Hepat. 2007;14:330-7.
     PubMed     Related articles    Abstract available
     
     
     
118. PILLAI V , Lee WM, Thiele DL, Karandikar NJ, et al
     Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.
     J Viral Hepat. 2007;14:318-29.
     PubMed     Related articles    Abstract available
     
     
     
119. COCO B , Oliveri F, Maina AM, Ciccorossi P, et al
     Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
     J Viral Hepat. 2007;14:360-9.
     PubMed     Related articles    Abstract available
     
     
     April 2007
120. RUIZ-FERRER M , Antinolo G, Aguilar-Reina J
     Analysis of the -844C > T polymorphism in the promoter region of FASLgene in a cohort of Spanish HCV patients.
     J Viral Hepat. 2007;14:293-4.
     PubMed     Related articles   
     
     
     
121. GOULDING C , O'brien C, Egan H, Hegarty JE, et al
     The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source.
     J Viral Hepat. 2007;14:255-9.
     PubMed     Related articles    Abstract available
     
     
     
122. JAYARAMAN GC , Lee B, Singh AE, Preiksaitis JK, et al
     Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population-based laboratory surveillance in Alberta, Canada (1998-2001).
     J Viral Hepat. 2007;14:249-54.
     PubMed     Related articles    Abstract available
     
     
     
123. SHIRE NJ , Welge JA, Sherman KE
     Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis.
     J Viral Hepat. 2007;14:239-48.
     PubMed     Related articles    Abstract available
     
     
     
124. CRESPO M , Sauleda S, Esteban JI, Juarez A, et al
     Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
     J Viral Hepat. 2007;14:228-38.
     PubMed     Related articles    Abstract available
     
     
     
125. MANGIA A
     Short-duration therapy for hepatitis C: suitable for all?
     J Viral Hepat. 2007;14:221-227.
     PubMed     Related articles    Abstract available
     
     
     March 2007
126. HARRIS HE , Eldridge KP, Harbour S, Alexander G, et al
     Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?
     J Viral Hepat. 2007;14:213-20.
     PubMed     Related articles    Abstract available
     
     
     
127. SMITH RM , Smolic R, Volarevic M, Wu GY, et al
     Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
     J Viral Hepat. 2007;14:194-212.
     PubMed     Related articles    Abstract available
     
     
     
128. ROSENTHAL E , Pialoux G, Bernard N, Pradier C, et al
     Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).
     J Viral Hepat. 2007;14:183-8.
     PubMed     Related articles    Abstract available
     
     
     February 2007
129. KORF M , Meyer A, Jarczak D, Beger C, et al
     Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters.
     J Viral Hepat. 2007;14:122-32.
     PubMed     Related articles    Abstract available
     
     
     
130. CALLERI G , Cariti G, Gaiottino F, De Rosa FG, et al
     A short course of pegylated interferon-alpha in acute HCV hepatitis.
     J Viral Hepat. 2007;14:116-121.
     PubMed     Related articles    Abstract available
     
     
     
131. DEUFFIC-BURBAN S , Poynard T, Sulkowski MS, Wong JB, et al
     Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.
     J Viral Hepat. 2007;14:107-15.
     PubMed     Related articles    Abstract available
     
     
     
132. VALLET S , Gouriou S, Nkontchou G, Hotta H, et al
     Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?
     J Viral Hepat. 2007;14:96-106.
     PubMed     Related articles    Abstract available
     
     
     
133. SALMERON J , Diago M, Andrade R, Perez R, et al
     Induction doses of interferon-alpha-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial.
     J Viral Hepat. 2007;14:89-95.
     PubMed     Related articles    Abstract available
     
     
     January 2007
134. UMEMURA T , Muto H, Tanaka E, Matsumoto A, et al
     Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.
     J Viral Hepat. 2007;14:48-54.
     PubMed     Related articles    Abstract available
     
     
     
135. PARDO M , Lopez-Alcorocho JM, Rodriguez-Inigo E, Castillo I, et al
     Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
     J Viral Hepat. 2007;14:36-40.
     PubMed     Related articles    Abstract available
     
     
     
136. WESTIN J , Lagging M, Dhillon AP, Norkrans G, et al
     Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.
     J Viral Hepat. 2007;14:29-35.
     PubMed     Related articles    Abstract available
     
     
     
137. CAINI P , Guerra CT, Giannini C, Giannelli F, et al
     Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
     J Viral Hepat. 2007;14:22-28.
     PubMed     Related articles    Abstract available
     
     
     
138. KAYALI Z , Tan S, Shinkunas L, Voigt M, et al
     Risk factors for hepatitis C fibrosis: a prospective study of United States veterans* compared with nonveterans.
     J Viral Hepat. 2007;14:11-21.
     PubMed     Related articles    Abstract available
     
     
     
139. SHEEHY P , Mullan B, Moreau I, Kenny-Walsh E, et al
     In vitro replication models for the hepatitis C virus.
     J Viral Hepat. 2007;14:2-10.
     PubMed     Related articles    Abstract available
     
     
     
140. SATRA M , Gatselis N, Iliopoulos D, Zacharoulis D, et al
     Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
     J Viral Hepat. 2007;14:41-7.
     PubMed     Related articles    Abstract available
     
     
     December 2006
141. VON WAGNER M , Lee JH, Kronenberger B, Friedl R, et al
     Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels.
     J Viral Hepat. 2006;13:828-834.
     PubMed     Related articles    Abstract available
     
     
     
142. ACETI A , Mangoni ML, Pasquazzi C, Fiocco D, et al
     alpha-Defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection.
     J Viral Hepat. 2006;13:821-827.
     PubMed     Related articles    Abstract available
     
     
     
143. ABERGEL A , Hezode C, Leroy V, Barange K, et al
     Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.
     J Viral Hepat. 2006;13:811-820.
     PubMed     Related articles    Abstract available
     
     
     
144. BACKUS LI , Boothroyd DB, Phillips BR, Mole LA, et al
     Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
     J Viral Hepat. 2006;13:799-810.
     PubMed     Related articles    Abstract available
     
     
     
145. MARTIN-CARBONERO L , Sanchez-Somolinos M, Garcia-Samaniego J, Nunez MJ, et al
     Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
     J Viral Hepat. 2006;13:851-7.
     PubMed     Related articles    Abstract available
     
     
     November 2006
146. NARASIMHAN G , Sargios TN, Kalakuntla R, Homel P, et al
     Treatment rates in patients with chronic hepatitis C after liver biopsy.
     J Viral Hepat. 2006;13:783-6.
     PubMed     Related articles    Abstract available
     
     
     
147. KARMOCHKINE M , Carrat F, Dos Santos O, Cacoub P, et al
     A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection*.
     J Viral Hepat. 2006;13:775-82.
     PubMed     Related articles    Abstract available
     
     
     
148. DAI CY , Chuang WL, Lee LP, Chen SC, et al
     Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C.
     J Viral Hepat. 2006;13:770-4.
     PubMed     Related articles    Abstract available
     
     
     
149. HELBLING B , Jochum W, Stamenic I, Knopfli M, et al
     HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin.
     J Viral Hepat. 2006;13:762-9.
     PubMed     Related articles    Abstract available
     
     
     
150. KONISHI M , Wu CH, Kaito M, Hayashi K, et al
     siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations.
     J Viral Hepat. 2006;13:756-61.
     PubMed     Related articles    Abstract available
     
     
     
151. SHIMIZU YK , Hijikata M, Oshima M, Shimizu K, et al
     Detection of a 5' end subgenome of hepatitis C virus terminating at nucleotide 384 in patients' plasma and liver tissues.
     J Viral Hepat. 2006;13:746-55.
     PubMed     Related articles    Abstract available
     
     
     October 2006
152. ULSENHEIMER A , Lucas M, Seth NP, Tilman Gerlach J, et al
     Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.
     J Viral Hepat. 2006;13:708-14.
     PubMed     Related articles    Abstract available
     
     
     
153. MARTINOT-PEIGNOUX M , Comanor L, Minor JM, Ripault MP, et al
     Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.
     J Viral Hepat. 2006;13:701-7.
     PubMed     Related articles    Abstract available
     
     
     
154. ITSUI Y , Sakamoto N, Kurosaki M, Kanazawa N, et al
     Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
     J Viral Hepat. 2006;13:690-700.
     PubMed     Related articles    Abstract available
     
     
     
155. ALVAREZ D , Dieterich DT, Brau N, Moorehead L, et al
     Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.
     J Viral Hepat. 2006;13:683-9.
     PubMed     Related articles    Abstract available
     
     
     
156. CACOUB P , Rosenthal E, Halfon P, Sene D, et al
     Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
     J Viral Hepat. 2006;13:678-82.
     PubMed     Related articles    Abstract available
     
     
     
157. BOURLIERE M , Penaranda G, Renou C, Botta-Fridlund D, et al
     Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
     J Viral Hepat. 2006;13:659-70.
     PubMed     Related articles    Abstract available
     
     
     
158. CHRISTENSEN C , Bruden D, Livingston S, Deubner H, et al
     Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
     J Viral Hepat. 2006;13:652-8.
     PubMed     Related articles    Abstract available
     
     
     
159. TROCME C , Leroy V, Sturm N, Hilleret MN, et al
     Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
     J Viral Hepat. 2006;13:643-51.
     PubMed     Related articles    Abstract available
     
     
     September 2006
160. CARRIERE M , Rosenberg AR, Conti F, Chouzenoux S, et al
     Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption.
     J Viral Hepat. 2006;13:633-42.
     PubMed     Related articles    Abstract available
     
     
     
161. CLEMENTE M , Nunez O, Lorente R, Rincon D, et al
     Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis.
     J Viral Hepat. 2006;13:625-32.
     PubMed     Related articles    Abstract available
     
     
     
162. GREENBERG PD , Rosman AS, Eldeiry LS, Naqvi Z, et al
     Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C*.
     J Viral Hepat. 2006;13:613-7.
     PubMed     Related articles    Abstract available
     
     
     
163. KOHASHI T , Maekawa S, Sakamoto N, Kurosaki M, et al
     Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication.
     J Viral Hepat. 2006;13:582-90.
     PubMed     Related articles    Abstract available
     
     
     
164. DE MITRI MS , Cassini R, Morsica G, Bagaglio S, et al
     Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
     J Viral Hepat. 2006;13:574-81.
     PubMed     Related articles    Abstract available
     
     
     
165. LOCK G , Dirscherl M, Obermeier F, Gelbmann CM, et al
     Hepatitis C - contamination of toothbrushes: myth or reality?
     J Viral Hepat. 2006;13:571-3.
     PubMed     Related articles    Abstract available
     
     
     August 2006
166. MATHEI C , Shkedy Z, Denis B, Kabali C, et al
     Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users.
     J Viral Hepat. 2006;13:560-70.
     PubMed     Related articles    Abstract available
     
     
     
167. BRANDAO C , Barone A, Carrilho F, Silva A, et al
     The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1.
     J Viral Hepat. 2006;13:552-9.
     PubMed     Related articles    Abstract available
     
     
     
168. FELIU A , Carrion JA, Massaguer A, Martinez-Bauer E, et al
     Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection.
     J Viral Hepat. 2006;13:544-51.
     PubMed     Related articles    Abstract available
     
     
     
169. DUMORTIER J , Ducos E, Scoazec JY, Chevallier P, et al
     Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon alpha-2b and ribavirin combination after liver transplantation.
     J Viral Hepat. 2006;13:538-43.
     PubMed     Related articles    Abstract available
     
     
     
170. BERNARDIN F , Herring B, Page-Shafer K, Kuiken C, et al
     Absence of HCV viral recombination following superinfection.
     J Viral Hepat. 2006;13:532-7.
     PubMed     Related articles    Abstract available
     
     
     
171. IWAI A , Marusawa H, Takada Y, Egawa H, et al
     Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection.
     J Viral Hepat. 2006;13:523-31.
     PubMed     Related articles    Abstract available
     
     
     
172. LAYDEN-ALMER JE , Cotler SJ, Layden TJ
     Viral kinetics in the treatment of chronic hepatitis C.
     J Viral Hepat. 2006;13:499-504.
     PubMed     Related articles    Abstract available
     
     
     July 2006
173. GALLEGOS-OROZCO JF , Arenas JI, Vargas HE, Kibler KV, et al
     Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.
     J Viral Hepat. 2006;13:489-98.
     PubMed     Related articles    Abstract available
     
     
     
174. CASTERA L , Constant A, Bernard PH, de Ledinghen V, et al
     Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C.
     J Viral Hepat. 2006;13:482-8.
     PubMed     Related articles    Abstract available
     
     
     
175. BONILLA N , Barget N, Andrieu M, Roulot D, et al
     Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis - ANRS HC EP07 study*.
     J Viral Hepat. 2006;13:474-81.
     PubMed     Related articles    Abstract available
     
     
     
176. MORENO A , Barcena R, Garcia-Garzon S, Moreno L, et al
     Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus*.
     J Viral Hepat. 2006;13:466-73.
     PubMed     Related articles    Abstract available
     
     
     
177. MEYER-WYSS B , Rich P, Egger H, Helbling B, et al
     Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 mug/kg) combined with ribavirin in interferon-naive patients with chronic hepatitis C and up to moderate fibrosis.
     J Viral Hepat. 2006;13:457-65.
     PubMed     Related articles    Abstract available
     
     
     
178. FUJITA N , Kaito M, Kai M, Sugimoto R, et al
     Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
     J Viral Hepat. 2006;13:441-8.
     PubMed     Related articles    Abstract available
     
     
     
179. BERG C , Goncales FL Jr, Bernstein DE, Sette H Jr, et al
     Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin.
     J Viral Hepat. 2006;13:435-40.
     PubMed     Related articles    Abstract available
     
     
     
180. MERCHANTE N , Macias J, Ramayo E, Vergara S, et al
     Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
     J Viral Hepat. 2006;13:449-56.
     PubMed     Related articles    Abstract available
     
     
     June 2006
181. HUNG CH , Lee CM, Lu SN, Wang JH, et al
     Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
     J Viral Hepat. 2006;13:409-14.
     PubMed     Related articles    Abstract available
     
     
     
182. COZZI A , Zignego AL, Carpendo R, Biagiotti T, et al
     Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.
     J Viral Hepat. 2006;13:402-8.
     PubMed     Related articles    Abstract available
     
     
     
183. HUANG JF , Chuang WL, Dai CY, Chen SC, et al
     The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
     J Viral Hepat. 2006;13:396-401.
     PubMed     Related articles    Abstract available
     
     
     
184. HORNBERGER J , Farci P, Prati D, Zeuzem S, et al
     The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.
     J Viral Hepat. 2006;13:377-86.
     PubMed     Related articles    Abstract available
     
     
     
185. HOWELL CD , Jeffers LS, Cassidy W, Reddy KR, et al
     Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response.
     J Viral Hepat. 2006;13:371-6.
     PubMed     Related articles    Abstract available
     
     
     May 2006
186. STROFFOLINI T , Sagnelli E, Mariano A, Craxi A, et al
     Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6 999 cases.
     J Viral Hepat. 2006;13:351-4.
     PubMed     Related articles    Abstract available
     
     
     
187. MUIR AJ , Sylvestre PB, Rockey DC
     Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
     J Viral Hepat. 2006;13:322-8.
     PubMed     Related articles    Abstract available
     
     
     
188. BRUCHFELD A , Lindahl K, Reichard O, Carlsson T, et al
     Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
     J Viral Hepat. 2006;13:316-21.
     PubMed     Related articles    Abstract available
     
     
     
189. DESMOND CP , Roberts SK, Dudley F, Mitchell J, et al
     Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting.
     J Viral Hepat. 2006;13:311-5.
     PubMed     Related articles    Abstract available
     
     
     
190. BOCCATO S , Pistis R, Noventa F, Guido M, et al
     Fibrosis progression in initially mild chronic hepatitis C.
     J Viral Hepat. 2006;13:297-302.
     PubMed     Related articles    Abstract available
     
     
     
191. PERSICO M , Perrotta S, Persico E, Terracciano L, et al
     Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
     J Viral Hepat. 2006;13:290-6.
     PubMed     Related articles    Abstract available
     
     
     
192. MAIN J , Thomas H
     Mild hepatitis C: treat or monitor.
     J Viral Hepat. 2006;13:289.
     PubMed     Related articles   
     
     
     
193. BROWN RS JR
     Evaluating the evidence from clinical trials in chronic hepatitis C.
     J Viral Hepat. 2006;13 Suppl 1:15-25.
     PubMed     Related articles    Abstract available
     
     
     
194. O'BRIEN C
     Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C.
     J Viral Hepat. 2006;13 Suppl 1:6-14.
     PubMed     Related articles    Abstract available
     
     
     
195. BACON BR
     Assessing evidence from clinical trials in chronic hepatitis C.
     J Viral Hepat. 2006;13 Suppl 1:1-5.
     PubMed     Related articles    Abstract available
     
     
     
196. PAPATHEODORIDIS GV , Chrysanthos N, Savvas S, Sevastianos V, et al
     Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
     J Viral Hepat. 2006;13:303-10.
     PubMed     Related articles    Abstract available
     
     
     April 2006
197. FLOREANI A , Betterle C, Carderi I, Presotto F, et al
     Is hepatitis C virus a risk factor for thyroid autoimmunity?
     J Viral Hepat. 2006;13:272-7.
     PubMed     Related articles    Abstract available
     
     
     
198. IRVING WL , Smith S, Cater R, Pugh S, et al
     Clinical pathways for patients with newly diagnosed hepatitis C - What actually happens.
     J Viral Hepat. 2006;13:264-71.
     PubMed     Related articles    Abstract available
     
     
     
199. BRAU N , Bini EJ, Currie S, Shen H, et al
     Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.
     J Viral Hepat. 2006;13:242-9.
     PubMed     Related articles    Abstract available
     
     
     
200. CHAINUVATI S , Khalid SK, Kancir S, Shea M, et al
     Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disordersdagger.
     J Viral Hepat. 2006;13:235-41.
     PubMed     Related articles    Abstract available
     
     
     
201. MARIN-SERRANO E , Rodriguez-Ramos C, Diaz F, Martin-Herrera L, et al
     Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin.
     J Viral Hepat. 2006;13:230-4.
     PubMed     Related articles    Abstract available
     
     
     
202. MOGHADDAM A , Reinton N, Dalgard O
     A rapid real-time PCR assay for determination of hepatitis C virus genotypes 1, 2 and 3a.
     J Viral Hepat. 2006;13:222-9.
     PubMed     Related articles    Abstract available
     
     
     March 2006
203. KEW MC
     Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis.
     J Viral Hepat. 2006;13:145-9.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: